Physician profile
Cameron West
NPI 1952539421
$617.75
in general payments reported to CMS, 2019-2025
16 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.92 · 2022: $229 · 2023: $220 · 2024: $16.14 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $374.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $115.77 | 2022-2025 | Otezla |
| Janssen Biotech, INC. | $74.30 | 2022-2023 | Tremfya, Remicade, Stelara |
| Abbvie INC. | $50.17 | 2022-2023 | Rinvoq |
| Novartis Pharmaceuticals Corporation | $46.33 | 2022-2025 | |
| Galderma Laboratories, L.P. | $45.02 | 2023 | |
| Dermavant Sciences, INC. | $42.28 | 2022-2023 | Vtama |
| Organon LLC | $40.39 | 2025 | Vtama |
| Sun Pharmaceutical Industries INC. | $38.66 | 2022-2023 | Winlevi |
| E.R. Squibb & Sons, L.L.C. | $33.14 | 2022-2023 | Sotyktu |
| Ucb, INC. | $29.59 | 2022-2023 | Cimzia |
| Organogenesis INC. | $22.30 | 2023 | Puraply |
| Leo Pharma INC. | $18.67 | 2023 | Adbry |
| Genentech USA, INC. | $16.14 | 2024 | Xolair |
| Lilly USA, LLC | $15.96 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $15.11 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $13.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cameron West listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.